{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:10:23Z","timestamp":1784229023468,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270171"],"award-info":[{"award-number":["32270171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070155"],"award-info":[{"award-number":["32070155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["3154070031"],"award-info":[{"award-number":["3154070031"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72980-x","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:44:51Z","timestamp":1778521491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HTLV-1 subverts the innate immune effector gene IRF7 by viral HBZ protein for oncogenesis"],"prefix":"10.1038","volume":"17","author":[{"given":"Xiaoyi","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6102-8500","authenticated-orcid":false,"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2142-776X","authenticated-orcid":false,"given":"Dongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0473-754X","authenticated-orcid":false,"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2003-7201","authenticated-orcid":false,"given":"Guangyong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"72980_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805\u2013820 (2010).","journal-title":"Cell"},{"key":"72980_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1101\/sqb.2013.78.020321","volume":"78","author":"H Ikushima","year":"2013","unstructured":"Ikushima, H., Negishi, H. & Taniguchi, T. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb. Symp. Quant. Biol. 78, 105\u2013116 (2013).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"72980_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/gene.2011.21","volume":"12","author":"S Ning","year":"2011","unstructured":"Ning, S., Pagano, J. S. & Barber, G. N. IRF7: activation, regulation, modification and function. Genes Immun. 12, 399\u2013414 (2011).","journal-title":"Genes Immun."},{"key":"72980_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.immuni.2004.11.011","volume":"22","author":"Y Yu","year":"2005","unstructured":"Yu, Y., Wang, S. E. & Hayward, G. S. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22, 59\u201370 (2005).","journal-title":"Immunity"},{"key":"72980_CR5","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1073\/pnas.082420599","volume":"99","author":"FX Zhu","year":"2002","unstructured":"Zhu, F. X. et al. A Kaposi\u2019s sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl. Acad. Sci. USA 99, 5573\u20135578 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72980_CR6","doi-asserted-by":"publisher","first-page":"10040","DOI":"10.1128\/JVI.79.15.10040-10052.2005","volume":"79","author":"AM Hahn","year":"2005","unstructured":"Hahn, A. M. et al. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J. Virol. 79, 10040\u201310052 (2005).","journal-title":"J. Virol."},{"key":"72980_CR7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1128\/JVI.74.3.1061-1068.2000","volume":"74","author":"L Zhang","year":"2000","unstructured":"Zhang, L. & Pagano, J. S. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. J. Virol. 74, 1061\u20131068 (2000).","journal-title":"J. Virol."},{"key":"72980_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1006\/scbi.2001.0411","volume":"11","author":"L Zhang","year":"2001","unstructured":"Zhang, L. & Pagano, J. S. Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation. Semin Cancer Biol. 11, 445\u2013453 (2001).","journal-title":"Semin Cancer Biol."},{"key":"72980_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.virusres.2014.09.005","volume":"195","author":"D Xu","year":"2015","unstructured":"Xu, D. et al. Interferon regulatory factor 7 is involved in the growth of Epstein-Barr virus-transformed human B lymphocytes. Virus Res 195, 112\u2013118 (2015).","journal-title":"Virus Res"},{"key":"72980_CR10","doi-asserted-by":"crossref","unstructured":"Tu, J. J. et al. The past, present, and future of a human T-cell leukemia virus type 1 vaccine. Front. Microbiol. 10.3389\/fmicb.2022.897346 (2022).","DOI":"10.3389\/fmicb.2022.897346"},{"key":"72980_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","volume":"36","author":"CRM Bangham","year":"2018","unstructured":"Bangham, C. R. M. Human T cell leukemia virus type 1: Persistence and pathogenesis. Annu. Rev. Immunol. 36, 43\u201371 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"72980_CR12","doi-asserted-by":"publisher","first-page":"e1006722","DOI":"10.1371\/journal.ppat.1006722","volume":"13","author":"R Furuta","year":"2017","unstructured":"Furuta, R. et al. Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo. PLoS Pathog. 13, e1006722 (2017).","journal-title":"PLoS Pathog."},{"key":"72980_CR13","first-page":"2299","volume":"141","author":"CRM Bangham","year":"2023","unstructured":"Bangham, C. R. M. HTLV-1 persistence and the oncogenesis of adult T-cell leukemia\/lymphoma. Blood 141, 2299\u20132306 (2023).","journal-title":"Blood"},{"key":"72980_CR14","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/sj.bjc.6605345","volume":"101","author":"M Boxus","year":"2009","unstructured":"Boxus, M. & Willems, L. Mechanisms of HTLV-1 persistence and transformation. Br. J. Cancer 101, 1497\u20131501 (2009).","journal-title":"Br. J. Cancer"},{"key":"72980_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pathogens9070543","volume":"9","author":"S Mohanty","year":"2020","unstructured":"Mohanty, S. & Harhaj, E. W. Mechanisms of Oncogenesis by HTLV-1 Tax. Pathogens 9, 543 (2020).","journal-title":"Pathogens"},{"key":"72980_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-016-0249-x","volume":"13","author":"G Ma","year":"2016","unstructured":"Ma, G., Yasunaga, J.-I. & Matsuoka, M. Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis. Retrovirology 13, 16 (2016).","journal-title":"Retrovirology"},{"key":"72980_CR17","doi-asserted-by":"publisher","first-page":"e28424","DOI":"10.1002\/jmv.28424","volume":"95","author":"X Zuo","year":"2023","unstructured":"Zuo, X. et al. HTLV-1 persistent infection and ATLL oncogenesis. J. Med Virol. 95, e28424 (2023).","journal-title":"J. Med Virol."},{"key":"72980_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12111","volume":"496","author":"K Howe","year":"2013","unstructured":"Howe, K. et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 496, 498\u2013503 (2013).","journal-title":"Nature"},{"key":"72980_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.genet.39.073003.095931","volume":"39","author":"JL de Jong","year":"2005","unstructured":"de Jong, J. L. & Zon, L. I. Use of the zebrafish system to study primitive and definitive hematopoiesis. Annu Rev. Genet 39, 481\u2013501 (2005).","journal-title":"Annu Rev. Genet"},{"key":"72980_CR20","doi-asserted-by":"publisher","first-page":"902941","DOI":"10.3389\/fimmu.2022.902941","volume":"13","author":"M Stosik","year":"2022","unstructured":"Stosik, M., Tokarz-Deptu\u0142a, B. & Deptu\u0142a, W. Haematopoiesis in Zebrafish (Danio Rerio). Front Immunol. 13, 902941 (2022).","journal-title":"Front Immunol."},{"key":"72980_CR21","doi-asserted-by":"crossref","unstructured":"Rasighaemi, P. et al. Zebrafish as a model for leukemia and other hematopoietic disorders. J. Hematol. Oncol. 8, 29 (2015).","DOI":"10.1186\/s13045-015-0126-4"},{"key":"72980_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13619-022-00139-2","volume":"12","author":"Y-X Hu","year":"2023","unstructured":"Hu, Y.-X. & Jing, Q. Zebrafish: A convenient tool for myelopoiesis research. Cell Regeneration (Lond., Engl.) 12, 2 (2023).","journal-title":"Cell Regeneration (Lond., Engl.)"},{"key":"72980_CR23","doi-asserted-by":"publisher","first-page":"199327","DOI":"10.1016\/j.virusres.2024.199327","volume":"341","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Application of the zebrafish model in human viral research. Virus Res 341, 199327 (2024).","journal-title":"Virus Res"},{"key":"72980_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/978-1-4939-8831-0_26","volume":"1874","author":"W Pei","year":"2019","unstructured":"Pei, W. & Burgess, S. M. Microinjection in Zebrafish for Genome Editing and Functional Studies. Methods Mol. Biol. 1874, 459\u2013474 (2019).","journal-title":"Methods Mol. Biol."},{"key":"72980_CR25","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1158\/0008-5472.CAN-15-0942","volume":"75","author":"Y Mitobe","year":"2015","unstructured":"Mitobe, Y. et al. HTLV-1 bZIP factor RNA and protein impart distinct functions on T-cell proliferation and survival. Cancer Res. 75, 4143\u20134152 (2015).","journal-title":"Cancer Res."},{"key":"72980_CR26","doi-asserted-by":"publisher","first-page":"e2014783118","DOI":"10.1073\/pnas.2014783118","volume":"118","author":"G Ma","year":"2021","unstructured":"Ma, G. et al. Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence. Proc. Natl. Acad. Sci. USA 118, e2014783118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72980_CR27","doi-asserted-by":"publisher","first-page":"e150472","DOI":"10.1172\/JCI150472","volume":"131","author":"BJ Tan","year":"2021","unstructured":"Tan, B. J. et al. HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia\/lymphoma. J. Clin. Invest 131, e150472 (2021).","journal-title":"J. Clin. Invest"},{"key":"72980_CR28","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.4049\/jimmunol.1401290","volume":"193","author":"KJ Lee","year":"2014","unstructured":"Lee, K. J. et al. Serine cluster phosphorylation liberates the C-terminal helix of IFN regulatory factor 7 to bind histone acetyltransferase p300. J. Immunol. 193, 4137\u20134148 (2014).","journal-title":"J. Immunol."},{"key":"72980_CR29","doi-asserted-by":"publisher","first-page":"34320","DOI":"10.1074\/jbc.M002814200","volume":"275","author":"R Lin","year":"2000","unstructured":"Lin, R., Mamane, Y. & Hiscott, J. Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 275, 34320\u201334327 (2000).","journal-title":"J. Biol. Chem."},{"key":"72980_CR30","doi-asserted-by":"publisher","first-page":"1236923","DOI":"10.3389\/fimmu.2023.1236923","volume":"14","author":"W Ma","year":"2023","unstructured":"Ma, W. et al. IRF7: role and regulation in immunity and autoimmunity. Front Immunol. 14, 1236923 (2023).","journal-title":"Front Immunol."},{"key":"72980_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1021\/acsmedchemlett.9b00027","volume":"10","author":"DW Thomson","year":"2019","unstructured":"Thomson, D. W. et al. Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor. ACS Med Chem. Lett. 10, 780\u2013785 (2019).","journal-title":"ACS Med Chem. Lett."},{"key":"72980_CR32","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1016\/j.bmcl.2007.04.088","volume":"17","author":"JA Christopher","year":"2007","unstructured":"Christopher, J. A. et al. The discovery of 2-amino-3,5-diarylbenzamide inhibitors of IKK-alpha and IKK-beta kinases. Bioorg. Med Chem. Lett. 17, 3972\u20133977 (2007).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"72980_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13578-023-01188-z","volume":"13","author":"L Ji","year":"2023","unstructured":"Ji, L. et al. The crucial regulatory role of type I interferon in inflammatory diseases. Cell Biosci. 13, 230 (2023).","journal-title":"Cell Biosci."},{"key":"72980_CR34","doi-asserted-by":"publisher","first-page":"1190841","DOI":"10.3389\/fimmu.2023.1190841","volume":"14","author":"F Qing","year":"2023","unstructured":"Qing, F. & Liu, Z. Interferon regulatory factor 7 in inflammation, cancer and infection. Front Immunol. 14, 1190841 (2023).","journal-title":"Front Immunol."},{"key":"72980_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00294-003-0393-4","volume":"43","author":"M Okamaoto","year":"2003","unstructured":"Okamaoto, M. et al. Ditercalinium chloride, a pro-anticancer drug, intimately associates with mammalian mitochondrial DNA and inhibits its replication. Curr. Genet 43, 364\u2013370 (2003).","journal-title":"Curr. Genet"},{"key":"72980_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1074-7613(00)80025-4","volume":"10","author":"R Moriggl","year":"1999","unstructured":"Moriggl, R. et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10, 249\u2013259 (1999).","journal-title":"Immunity"},{"key":"72980_CR37","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips, R. L. et al. The JAK-STAT pathway at 30: Much learned, much more to do. Cell 185, 3857\u20133876 (2022).","journal-title":"Cell"},{"key":"72980_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00920-3","volume":"7","author":"N Elumalai","year":"2017","unstructured":"Elumalai, N. et al. Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b. Sci. Rep. 7, 819 (2017).","journal-title":"Sci. Rep."},{"key":"72980_CR39","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1021\/acschembio.9b00137","volume":"14","author":"J Grab","year":"2019","unstructured":"Grab, J. et al. The STAT5b linker domain mediates the selectivity of catechol bisphosphates for STAT5b over STAT5a. ACS Chem. Biol. 14, 796\u2013805 (2019).","journal-title":"ACS Chem. Biol."},{"key":"72980_CR40","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/eji.201344279","volume":"44","author":"M Huber","year":"2014","unstructured":"Huber, M. & Lohoff, M. IRF4 at the crossroads of effector T-cell fate decision. Eur. J. Immunol. 44, 1886\u20131895 (2014).","journal-title":"Eur. J. Immunol."},{"key":"72980_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exphem.2022.07.300","volume":"114","author":"S Amanda","year":"2022","unstructured":"Amanda, S. et al. Lineage- and stage-specific oncogenicity of IRF4. Exp. Hematol. 114, 9\u201317 (2022).","journal-title":"Exp. Hematol."},{"key":"72980_CR42","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1128\/MCB.17.10.5748","volume":"17","author":"L Zhang","year":"1997","unstructured":"Zhang, L. & Pagano, J. S. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol. Cell Biol. 17, 5748\u20135757 (1997).","journal-title":"Mol. Cell Biol."},{"key":"72980_CR43","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ni1118","volume":"5","author":"T Kawai","year":"2004","unstructured":"Kawai, T. et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5, 1061\u20131068 (2004).","journal-title":"Nat. Immunol."},{"key":"72980_CR44","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nature03464","volume":"434","author":"K Honda","year":"2005","unstructured":"Honda, K. et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434, 772\u2013777 (2005).","journal-title":"Nature"},{"key":"72980_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1074-7613(00)00053-4","volume":"13","author":"M Sato","year":"2000","unstructured":"Sato, M. et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha\/beta gene induction. Immunity 13, 539\u2013548 (2000).","journal-title":"Immunity"},{"key":"72980_CR46","doi-asserted-by":"publisher","first-page":"e00853","DOI":"10.1128\/JVI.00853-17","volume":"91","author":"MS Narulla","year":"2017","unstructured":"Narulla, M. S. et al. Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ. J. Virol. 91, e00853\u201317 (2017).","journal-title":"J. Virol."},{"key":"72980_CR47","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nm.2830","volume":"18","author":"BN Bidwell","year":"2012","unstructured":"Bidwell, B. N. et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med 18, 1224\u20131231 (2012).","journal-title":"Nat. Med"},{"key":"72980_CR48","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/s41388-018-0624-2","volume":"38","author":"Q Lan","year":"2019","unstructured":"Lan, Q. et al. Type I interferon\/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer. Oncogene 38, 2814\u20132829 (2019).","journal-title":"Oncogene"},{"key":"72980_CR49","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/s41388-022-02233-w","volume":"41","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion. Oncogene 41, 2303\u20132314 (2022).","journal-title":"Oncogene"},{"key":"72980_CR50","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/emboj\/18.5.1367","volume":"18","author":"I Matsumura","year":"1999","unstructured":"Matsumura, I. et al. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18, 1367\u20131377 (1999).","journal-title":"EMBO J."},{"key":"72980_CR51","doi-asserted-by":"publisher","first-page":"e168536","DOI":"10.1172\/JCI168536","volume":"134","author":"T Suske","year":"2024","unstructured":"Suske, T. et al. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia. J. Clin. Invest 134, e168536 (2024).","journal-title":"J. Clin. Invest"},{"key":"72980_CR52","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1182\/blood.2021013568","volume":"139","author":"Y Kogure","year":"2022","unstructured":"Kogure, Y. et al. Whole-genome landscape of adult T-cell leukemia\/lymphoma. Blood 139, 967\u2013982 (2022).","journal-title":"Blood"},{"key":"72980_CR53","doi-asserted-by":"crossref","unstructured":"Matsuoka, M. & Green, P. L. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 6, 71 (2009).","DOI":"10.1186\/1742-4690-6-71"},{"key":"72980_CR54","doi-asserted-by":"publisher","first-page":"e20952","DOI":"10.1371\/journal.pone.0020952","volume":"6","author":"E Lion","year":"2011","unstructured":"Lion, E. et al. Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC. PLoS One 6, e20952 (2011).","journal-title":"PLoS One"},{"key":"72980_CR55","doi-asserted-by":"crossref","unstructured":"Rosen, J. N., Sweeney, M. F. & Mably, J. D. Microinjection of zebrafish embryos to analyze gene function. J. Vis. Exp. 10.3791\/1115 (2009).","DOI":"10.3791\/1115-v"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72980-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72980-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72980-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:02:17Z","timestamp":1784228537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72980-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72980"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72980-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6321"}}